Stockreport

Capricor Therapeutics: A Buy Ahead Of Phase 3 Topline And Clarified Regulatory Pathway [Seeking Alpha]

Capricor Therapeutics, Inc.  (CAPR) 
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors
PDF Topline results are expected this November. PUL 2.0 (a skeletal muscle endpoint) remains the primary endpoint, with left ventricle ejection fraction being a key seconda [Read more]